Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy K Starr

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Cytotherapy|July 17, 2025
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancersMatthew J Johnson, Darin Sumstad, Timothy D Folsom, et al.
International Journal of Cancer|October 30, 2016
Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasmsShelli M Morris, Jerry Davison, Kelly T Carter, et al.
Cancers|July 9, 2022
Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian CancerKristin L M Boylan, Ashley Petersen, Timothy K Starr, et al.
Molecular Cancer Research : MCR|May 22, 2015
Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor SuppressorCasey Dorr, Callie Janik, Madison Weg, et al.
Molecular Cancer Research : MCR|October 26, 2018
<i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell LymphomaEric P Rahrmann, Natalie K Wolf, George M Otto, et al.
Translational Oncology|December 23, 2021
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formationJianbo Yang, Qianjin Liao, Matthew Price, et al.
Nature Biomedical Engineering|December 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repairBeau R Webber, Matthew J Johnson, Joseph G Skeate, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Nature Biotechnology|February 24, 2009
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinomaVincent W Keng, Augusto Villanueva, Derek Y Chiang, et al.
Gastroenterology|August 10, 2020
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and MetastasisAshutosh Tiwari, Kojiro Tashiro, Ajay Dixit, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Cytotherapy|July 17, 2025
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancersMatthew J Johnson, Darin Sumstad, Timothy D Folsom, et al.
International Journal of Cancer|October 30, 2016
Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasmsShelli M Morris, Jerry Davison, Kelly T Carter, et al.
Cancers|July 9, 2022
Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian CancerKristin L M Boylan, Ashley Petersen, Timothy K Starr, et al.
Molecular Cancer Research : MCR|May 22, 2015
Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor SuppressorCasey Dorr, Callie Janik, Madison Weg, et al.
Molecular Cancer Research : MCR|October 26, 2018
<i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell LymphomaEric P Rahrmann, Natalie K Wolf, George M Otto, et al.
Translational Oncology|December 23, 2021
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formationJianbo Yang, Qianjin Liao, Matthew Price, et al.
Nature Biomedical Engineering|December 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repairBeau R Webber, Matthew J Johnson, Joseph G Skeate, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Nature Biotechnology|February 24, 2009
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinomaVincent W Keng, Augusto Villanueva, Derek Y Chiang, et al.
Gastroenterology|August 10, 2020
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and MetastasisAshutosh Tiwari, Kojiro Tashiro, Ajay Dixit, et al.
Pageof 6